Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs

T Ooie, H Suzuki, T Terasaki and Y Sugiyama

Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.

The distribution of the quinolone antibiotics, norfloxacin (NFLX), AM- 1155, fleroxacin (FLRX), ofloxacin, sparfloxacin (SPFX) and pefloxacin (PFLX), in the central nervous system (CNS) was investigated in dogs and rats. In dogs, the steady-state cerebrospinal fluid (CSF) to unbound serum concentration ratio (Kp,uCSF) differed widely ranging from 0.11 (NFLX) to 1.0 (PFLX). About a 10-fold difference between compounds was also observed in the Kp,uCSF in rats; however, these values were 25 to 50% smaller than those in dogs. Similarly, the brain to unbound serum concentration ratio (Kp,uBrain) of quinolones differed widely ranging from 0.15 (NFLX) to 1.5 (SPFX) in dogs and 0.04 (NFLX) to 0.33 (FLRX) in rats. The steady-state concentration ratio between CSF and brain tissue exhibited a 3-fold difference among quinolones (0.5 for PFLX to 1.6 for SPFX) in dogs, whereas, these values were all close to unity in rats. Kp,uBrain and Kp,uCSF all increased as the lipophilicity of the compound increased (except the Kp,uBrain in dogs). We also found that the quinolones inhibited the saturable accumulation of [14C]FLRX (Km 660 microM) by the isolated rat choroid plexus. About a 20-fold difference among the apparent IC50 values for FLRX transport was observed between NFLX (6000 microM) and PFLX (300 microM). The absence of a negative correlation between the affinity of the quinolones for this transport system, which in turn represents the efflux clearance from the CSF, and their in vivo distribution in rat CNS (Kp,uBrain or Kp,uCSF) suggests a minor contribution of this efflux system to the CNS distribution of quinolones.

Volume 278, Issue 2, pp. 590-596, 08/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				H. Sasabe, Y. Kato, T. Suzuki, M. Itose, G. Miyamoto, and Y. Sugiyama Differential Involvement of Multidrug Resistance-Associated Protein 1 and P-Glycoprotein in Tissue Distribution and Excretion of Grepafloxacin in Mice J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 648 - 655. [Abstract] [Full Text] [PDF]

				M. Takahata, H. Yamada, T. Morita, S. Furubou, S. Minami, Y. Todo, Y. Watanabe, and H. Narita Evaluation of T-3811ME (BMS-284756), a New Des-F(6)-Quinolone, for Treatment of Meningitis Caused by Penicillin-Resistant Streptococcus pneumoniae in Rabbits Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1760 - 1765. [Abstract] [Full Text] [PDF]

				I. Tamai, J. Yamashita, Y. Kido, A. Ohnari, Y. Sai, Y. Shima, K. Naruhashi, S. Koizumi, and A. Tsuji Limited Distribution of New Quinolone Antibacterial Agents into Brain Caused by Multiple Efflux Transporters at the Blood-Brain Barrier J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 146 - 152. [Abstract] [Full Text]

				A. Smirnov, A. Wellmer, J. Gerber, K. Maier, S. Henne, and R. Nau Gemifloxacin Is Effective in Experimental Pneumococcal Meningitis Antimicrob. Agents Chemother., March 1, 2000; 44(3): 767 - 770. [Abstract] [Full Text]

				M. V. Moretti, S. Pauluzzi, and M. Cesana Penetration of Rufloxacin into the Cerebrospinal Fluid in Patients with Inflamed and Uninflamed Meninges Antimicrob. Agents Chemother., January 1, 2000; 44(1): 73 - 77. [Abstract] [Full Text]

				A. De Sarro, V. Cecchetti, V. Fravolini, F. Naccari, O. Tabarrini, and G. De Sarro Effects of Novel 6-Desfluoroquinolones and Classic Quinolones on Pentylenetetrazole-Induced Seizures in Mice Antimicrob. Agents Chemother., July 1, 1999; 43(7): 1729 - 1736. [Abstract] [Full Text]

				I. Lutsar, I. R. Friedland, H. S. Jafri, L. Wubbel, W. Ng, F. Ghaffar, and G. H. McCracken Jr. Efficacy of Gatifloxacin in Experimental Escherichia coli Meningitis Antimicrob. Agents Chemother., July 1, 1999; 43(7): 1805 - 1807. [Abstract] [Full Text]

				M. Murata, I. Tamai, H. Kato, O. Nagata, H. Kato, and A. Tsuji Efflux Transport of a New Quinolone Antibacterial Agent, HSR-903, across the Blood-Brain Barrier J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 51 - 57. [Abstract] [Full Text]

				C. C. McCoig, L. Wubbel, H. S. Jafri, I. Lutsar, R. Bastero, K. Olsen, S. Shelton, I. R. Friedland, and G. H. McCracken Pharmacodynamics of trovafloxacin in experimental pneumococcal meningitis: basis for dosage selection in children with meningitis J. Antimicrob. Chemother., May 1, 1999; 43(5): 683 - 688. [Abstract] [Full Text] [PDF]

				I. Lutsar, I. R. Friedland, L. Wubbel, C. C. McCoig, H. S. Jafri, W. Ng, F. Ghaffar, and G. H. McCracken Jr. Pharmacodynamics of Gatifloxacin in Cerebrospinal Fluid in Experimental Cephalosporin-Resistant Pneumococcal Meningitis Antimicrob. Agents Chemother., October 1, 1998; 42(10): 2650 - 2655. [Abstract] [Full Text]

				C. Østergaard, T. Klitmøller Sørensen, J. Dahl Knudsen, and N. Frimodt-Møller Evaluation of Moxifloxacin, a New 8-Methoxyquinolone, for Treatment of Meningitis Caused by a PenicillinResistant Pneumococcus in Rabbits Antimicrob. Agents Chemother., July 1, 1998; 42(7): 1706 - 1712. [Abstract] [Full Text]

				T. Ooie, T. Terasaki, H. Suzuki, and Y. Sugiyama Kinetic Evidence for Active Efflux Transport across the Blood-Brain Barrier of Quinolone Antibiotics J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 293 - 304. [Abstract] [Full Text]

				T. Ito, I. Yano, K. Tanaka, and K.-I. Inui Transport of Quinolone Antibacterial Drugs by Human P-Glycoprotein Expressed in a Kidney Epithelial Cell Line, LLC-PK1 J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 955 - 960. [Abstract] [Full Text]

				T. Ooie, T. Terasaki, H. Suzuki, and Y. Sugiyama Quantitative Brain Microdialysis Study on the Mechanism of Quinolones Distribution in the Central Nervous System Drug Metab. Dispos., July 1, 1997; 25(7): 784 - 789. [Abstract] [Full Text]